These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16465939)

  • 1. [Endocrinology].
    Meyer P; Meier CA
    Rev Med Suisse; 2006 Jan; 2(47):15-8. PubMed ID: 16465939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives, hormone replacement therapy and thrombosis.
    Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
    Thromb Haemost; 2001 Jul; 86(1):112-23. PubMed ID: 11486996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    van de Weijer PH; Mattsson LA; Ylikorkala O
    Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.
    Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
    Eur Heart J; 2007 Aug; 28(16):2028-40. PubMed ID: 17644507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-dose hormonal therapy during climacteric].
    Carranza Lira S
    Ginecol Obstet Mex; 2008 May; 76(5):267-74. PubMed ID: 18798431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormones in wellness and disease prevention: common practices, current state of the evidence, and questions for the future.
    Schwartz ET; Holtorf K
    Prim Care; 2008 Dec; 35(4):669-705. PubMed ID: 18928825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and benefits of hormone replacement therapy for the prevention of cardiovascular disease.
    Sarrel PM
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):515-8. PubMed ID: 12497775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraception and hormone replacement therapy: management of their thromboembolic risk in the perioperative period].
    Chalhoub V; Edelman P; Staiti G; Benhamou D
    Ann Fr Anesth Reanim; 2008 May; 27(5):405-15. PubMed ID: 18472389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there second thoughts about the results of the WHI study?
    Haimov-Kochman R; Hochner-Celnikier D
    Acta Obstet Gynecol Scand; 2006; 85(4):387-93. PubMed ID: 16612699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal treatment in women and thrombosis].
    Kaaja R; Heikinheimo O; Rasi V
    Duodecim; 1999; 115(11):1235-43. PubMed ID: 11877844
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
    Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of testosterone use in women.
    Shufelt CL; Braunstein GD
    Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controversies surrounding on hormone replacement therapy during menopause].
    Cravioto MC
    Gac Med Mex; 2006; 142 Suppl 2():33-42. PubMed ID: 19031677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.